Cargando…

First report of concomitant subcutaneous defibrillator and phrenic nerve stimulator implantation in a patient with severe central sleep apnea and left ventricular systolic dysfunction

Detalles Bibliográficos
Autores principales:	Jameria, Zenith, Mokhlesi, Babak, Sauser, Emilie, Holloway, Sharon, Upadhyay, Gaurav A., Nayak, Hemal M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6962740/ https://www.ncbi.nlm.nih.gov/pubmed/31956502 http://dx.doi.org/10.1016/j.hrcr.2019.10.004

Ejemplares similares

Real-world safety of magnetic resonance imaging after His bundle pacemaker implantation
por: Carter, Spencer V., et al.
Publicado: (2020)

Respiratory rate trending as a cause for atrial lead noise: A first report in an implantable cardioverter-defibrillator patient
por: McClelland, Isla, et al.
Publicado: (2018)

Concomitant use and interaction of a subcutaneous implantable defibrillator and epicardial pacemaker
por: Kajiyama, Takatsugu, et al.
Publicado: (2021)

Dental management of a patient fitted with subcutaneous Implantable Cardioverter Defibrillator device and concomitant warfarin treatment
por: Shah, Altaf Hussain, et al.
Publicado: (2015)

De novo subcutaneous implantable cardioverter-defibrillator in patient with left ventricular assist device
por: Reichert, William, et al.
Publicado: (2020)

Predictors of Elevated Defibrillation Threshold with the Subcutaneous Implantable Cardioverter-defibrillator
por: Do, Khuyen, et al.
Publicado: (2017)

How to implant a phrenic nerve stimulator for treatment of central sleep apnea?
por: Augostini, Ralph S., et al.
Publicado: (2019)

Phrenic nerve stimulation for the treatment of central sleep apnea in patients with heart failure
por: Wang, Youmeng, et al.
Publicado: (2022)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
por: Nair, Krishnakumar, et al.
Publicado: (2014)

Subcutaneous defibrillator implantation in pediatric patients
por: Ertuğrul, İlker, et al.
Publicado: (2016)

Long-term efficacy and safety of phrenic nerve stimulation for the treatment of central sleep apnea
por: Fox, Henrik, et al.
Publicado: (2019)

Cryoballoon pulmonary vein isolation and voltage mapping for symptomatic atrial fibrillation 9 months after Watchman device implantation
por: Huang, Henry D., et al.
Publicado: (2017)

Case report: An unusual case of phrenic nerve stimulation in a patient with single chamber implantable cardioverter defibrillator
por: De Innocentiis, Carlo, et al.
Publicado: (2023)

Sex Differences in the Impact of Obstructive Sleep Apnea on Glucose Metabolism
por: Temple, Karla A., et al.
Publicado: (2018)

Subcutaneous Implantable Cardioverter Defibrillator: Early Experience
por: Souza, Fernando Sérgio Oliva, et al.
Publicado: (2017)

Comparative outcomes of subcutaneous and transvenous cardioverter-defibrillators
por: Liang, Jin-Jun, et al.
Publicado: (2019)

Subcutaneous implantable defibrillator in dextrocardia secondary to Lobectomy
por: Monkhouse, Christopher, et al.
Publicado: (2018)

Subcutaneous defibrillator implantation as a bridge until left ventricular function normalizes
por: Bisignani, Antonio, et al.
Publicado: (2017)

Eligibility for subcutaneous implantable cardioverter-defibrillator in patients with left ventricular assist device
por: Zormpas, Christos, et al.
Publicado: (2020)

Impediment in upper airway stabilizing forces assessed by phrenic nerve stimulation in sleep apnea patients
por: Sériès, F, et al.
Publicado: (2005)

Improving Nocturnal Hypoxemic Burden with Transvenous Phrenic Nerve Stimulation for the Treatment of Central Sleep Apnea
por: Oldenburg, Olaf, et al.
Publicado: (2020)

Effects of defibrillation shock in patients implanted with a subcutaneous defibrillator: a biomarker study
por: D’Onofrio, Antonio, et al.
Publicado: (2018)

Intraoperative Defibrillation Testing of Subcutaneous Implantable Cardioverter‐Defibrillator Systems—A Simple Issue?
por: Frommeyer, Gerrit, et al.
Publicado: (2016)

Successful defibrillation verification in subcutaneous implantable cardioverter‐defibrillator recipients by low‐energy shocks
por: Biffi, Mauro, et al.
Publicado: (2019)

Induced atrial fibrillation during defibrillation test on implantation of subcutaneous implantable cardioverter defibrillator
por: Kim, Ki-Hun, et al.
Publicado: (2020)

The “Defibrillation Testing, Why Not?” survey. Testing of subcutaneous and transvenous defibrillators in the Italian clinical practice()
por: Migliore, Federico, et al.
Publicado: (2022)

Implantation of a subcutaneous implantable cardioverter-defibrillator in a patient with epicardial defibrillation patches
por: Yoshizawa, Reisuke, et al.
Publicado: (2021)

A sustained ventricular tachycardia overlooked by subcutaneous implantable cardioverter-defibrillator but recognized by co-implanted transvenous implantable cardioverter defibrillator
por: Goto, Kentaro, et al.
Publicado: (2020)

Early inappropriate shock in a subcutaneous cardiac defibrillator due to subcutaneous air
por: Nishinarita, Ryo, et al.
Publicado: (2019)

Response to Comment on Grimaldi et al. Association of Obstructive Sleep Apnea in Rapid Eye Movement Sleep With Reduced Glycemic Control in Type 2 Diabetes: Therapeutic Implications. Diabetes Care 2014;37:355–363
por: Mokhlesi, Babak, et al.
Publicado: (2014)

“Left ventricular” AV nodal reentrant tachycardia: Case report and review of the literature
por: Green, John, et al.
Publicado: (2016)

Association of Obstructive Sleep Apnea in Rapid Eye Movement Sleep With Reduced Glycemic Control in Type 2 Diabetes: Therapeutic Implications
por: Grimaldi, Daniela, et al.
Publicado: (2014)

Ventricular tachycardia detection with the subcutaneous implantable cardioverter-defibrillator: Tracing the cause of an absent tracing
por: Mansour, Fadi, et al.
Publicado: (2019)

Subcutaneous implantable cardioverter‐defibrillator noise following left ventricular assist device implantation
por: Khetarpal, Banveet Kaur, et al.
Publicado: (2023)

Impact of physiological pacing on functional mitral regurgitation in systolic dysfunction: Initial echocardiographic remodeling findings after His bundle pacing
por: Upadhyay, Gaurav A., et al.
Publicado: (2021)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Successful defibrillation testing in patients undergoing elective subcutaneous implantable cardioverter-defibrillator generator replacement
por: de Veld, Jolien A, et al.
Publicado: (2023)

The learning curve associated with the introduction of the subcutaneous implantable defibrillator
por: Knops, Reinoud E., et al.
Publicado: (2016)

The subcutaneous implantable cardioverter defibrillator––review of the recent data
por: Westerman, Stacy B, et al.
Publicado: (2018)

Subcutaneous ICD lead position affects defibrillation threshold
por: Sugumar, Hariharan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9teod5r9kouvj38q867nhfpl7b